Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 22 May 2012
Vol. 5, Issue 225, p. ra38
[DOI: 10.1126/scisignal.2002767]

RESEARCH ARTICLES

Editor's Summary

Inflammasome Dependency Determines Therapy?
Multiple sclerosis (MS) is an inflammatory autoimmune disease in which the myelin sheath surrounding axons is destroyed by cells of the immune system. MS and experimental autoimmune encephalitis (EAE), an animal model of MS, can be ameliorated by interferon-β (IFN-β); however, IFN-β is not effective in all cases. Inoue et al. determined a mechanism by which IFN-β decreases the severity of EAE in mice by inhibiting the activity of the NLRP3 inflammasome. However, the authors also characterized a form of EAE that was independent of NLRP3 and was refractory to IFN-β. Given other reports that have suggested the involvement of inflammasomes in MS, it will be important to investigate whether patients who fail to respond to IFN-β have inflammasome-independent disease.

Citation: M. Inoue, K. L. Williams, T. Oliver, P. Vandenabeele, J. V. Rajan, E. A. Miao, M. L. Shinohara, Interferon-β Therapy Against EAE Is Effective Only When Development of the Disease Depends on the NLRP3 Inflammasome. Sci. Signal. 5, ra38 (2012).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Deregulated NLRP3 and NLRP1 Inflammasomes and Their Correlations with Disease Activity in Systemic Lupus Erythematosus.
Q. Yang, C. Yu, Z. Yang, Q. Wei, K. Mu, Y. Zhang, W. Zhao, X. Wang, W. Huai, and L. Han (2014)
J Rheumatol 41, 444-452
   Abstract »    Full Text »    PDF »
Protein kinase C{beta} as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
T. V. Lanz, S. Becker, M. Osswald, S. Bittner, M. K. Schuhmann, C. A. Opitz, S. Gaikwad, B. Wiestler, U. M. Litzenburger, F. Sahm, et al. (2013)
PNAS 110, 14735-14740
   Abstract »    Full Text »    PDF »
Inflammatory Cytokines at the Summits of Pathological Signal Cascades in Brain Diseases.
L. Steinman (2013)
Science Signaling 6, pe3
   Abstract »    Full Text »    PDF »
Cutting Edge: Nitric Oxide Inhibits the NLRP3 Inflammasome.
E. Hernandez-Cuellar, K. Tsuchiya, H. Hara, R. Fang, S. Sakai, I. Kawamura, S. Akira, and M. Mitsuyama (2012)
J. Immunol. 189, 5113-5117
   Abstract »    Full Text »    PDF »
NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.
M. Inoue, K. L. Williams, M. D. Gunn, and M. L. Shinohara (2012)
PNAS 109, 10480-10485
   Abstract »    Full Text »    PDF »
Science Signaling Podcast: 22 May 2012.
M. L. Shinohara and A. M. VanHook (2012)
Science Signaling 5, pc11
   Abstract »    Full Text »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882